DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hk4ddd/global) has announced the addition of the "Global Neurovascular Intervention Devices Market 2011-2015" report to their offering.
TechNavio's analysts forecast the Global Neurovascular Intervention Devices market to grow at a CAGR of 11.25 percent over the period 2011-2015 One of the key factors contributing to this market growth is the huge patient population with various neurological disorders. The Global Neurovascular Intervention Devices market has also been witnessing the trend of an increase in mergers and acquisitions. However, the high cost of neurovascular intervention treatment could pose a challenge to the growth of this market.
The key vendors dominating this market space are Covidien plc, Codman and Shurtleff Inc., Stryker Corp., and Terumo Medical Corp.
The other vendors mentioned in the report are Gore Medical, ITGI Medical Ltd., Neuro Interventional Therapeutics Inc., and Medtronic Inc.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''The Global Neurovascular Intervention Devices market is witnessing an increase in mergers and acquisitions. Vendors are opting for mergers and acquisitions to increase their global presence and expand their product portfolio, as well as to achieve economies of scale in the manufacturing of products. Vendors can focus better on product innovation and increase their profit margins by collaborating with each other. Thus, mergers and acquisitions enable companies to expand their global customer base and their portfolio of products and solutions. This is fuelling the growth of the Global Neurovascular Intervention Devices market.
According to the report, worldwide, the incidence of vascular diseases of the brain has been on the rise. In the last decade, people have become more prone to cerebrovascular diseases because of several risk factors such as unhealthy dietary habits, lack of exercise as a result of hectic lifestyles, the increase in smoking, the high prevalence of hypertension, high blood pressure, high blood cholesterol or triglyceride levels, and other health issues such as obesity and stress. The huge patient population with various neurological disorders presents immense growth opportunities for the market.
For more information visit http://www.researchandmarkets.com/research/hk4ddd/global